MVIS US Listed Biotech 25 Index

The modified market cap-weighted index tracks the performance of the largest and most liquid US-listed companies that generate at least 50% of their revenues from biotechnology. The pure-play index contains only companies which are engaged primarily in research and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. The MVIS US Listed Biotech 25 Index (MVBBH) has been licensed to underlie financial products with currently USD 349.49 million in assets under management.

Index Performance

Index performance of price, total return net and total return gross indices is displayed in realtime.

PeriodPriceTotal Return NetTotal Return Gross
Year-to-Date Performance13.25%13.61%13.74%
1-Year Performance-3.07%-2.59%-2.42%
3-Year Performance9.96%11.72%12.38%
5-Year Performance23.68%26.50%27.58%
Since Inception (29 Sep 2000)195.05%204.43%311.76%

Index Records

Index highs and lows of price, total return net and total return gross indices are displayed in realtime.

PeriodPriceTotal Return NetTotal Return Gross
All Time High/Low3,367.70 / 312.69 3,403.35 / 312.71 4,567.29 / 1,000.00
52-Weeks High/Low3,170.78 / 2,421.18 3,257.19 / 2,490.21 4,398.71 / 3,364.26
Quarter High/Low3,066.09 / 2,863.79 3,161.14 / 2,952.56 4,274.43 / 3,992.40
Month High/Low2,968.28 / 2,863.79 3,060.30 / 2,952.56 4,138.08 / 3,992.40

Index Correlation and Volatility

Index correlation to selected index peers and index volatility are updated daily.

Index Correlation
MSCI ACWI Biotechnology0.8743
DJ US Biotechnology TSM0.9377
Index Volatility
22-day Volatility18.90
250-day Volatility22.88

Component Performance

Displayed are the best and worst index components over a selected period of time. Data is updated daily.

Best 5 Components1-YearYear-to-Date1-Day
ALEXION PHARMACEUTICALS INC-1.84%17.95%3.06%
AMGEN INC6.54%7.25%0.38%
BIOGEN INC-32.07%-22.51%0.82%
BIOMARIN PHARMACEUTICAL INC-21.58%-8.14%2.24%
CELGENE CORP4.91%49.29%0.44%
CHARLES RIVER LABORATORIES7.92%14.59%0.20%
GILEAD SCIENCES INC-9.41%4.50%1.09%
ILLUMINA INC-12.35%-3.14%2.06%
INCYTE CORP23.63%35.35%2.34%
REGENERON PHARMACEUTICALS-21.34%-20.27%0.59%
SEATTLE GENETICS INC6.19%41.14%1.70%
UNITED THERAPEUTICS CORP-35.38%-23.99%1.81%
VERTEX PHARMACEUTICALS INC5.39%12.49%1.46%
ALNYLAM PHARMACEUTICALS INC-14.49%14.35%1.50%
GRIFOLS SA-ADR8.89%21.81%0.73%
ALLERGAN PLC-13.94%22.52%1.34%
BLUEBIRD BIO INC-25.50%19.26%-2.67%
IONIS PHARMACEUTICALS INC35.49%33.46%1.65%
NEUROCRINE BIOSCIENCES INC-14.05%37.73%1.36%
QIAGEN NV-9.00%1.02%1.84%
IQVIA HOLDINGS INC28.30%35.31%1.53%
NEKTAR THERAPEUTICS-72.55%-48.25%-0.58%
EXACT SCIENCES CORP138.22%88.95%-0.19%
SAREPTA THERAPEUTICS INC-21.40%-6.99%-0.56%
BEIGENE LTD-ADR-10.59%4.12%0.61%
Worst 5 Components1-YearYear-to-Date1-Day
ALEXION PHARMACEUTICALS INC-1.84%17.95%3.06%
AMGEN INC6.54%7.25%0.38%
BIOGEN INC-32.07%-22.51%0.82%
BIOMARIN PHARMACEUTICAL INC-21.58%-8.14%2.24%
CELGENE CORP4.91%49.29%0.44%
CHARLES RIVER LABORATORIES7.92%14.59%0.20%
GILEAD SCIENCES INC-9.41%4.50%1.09%
ILLUMINA INC-12.35%-3.14%2.06%
INCYTE CORP23.63%35.35%2.34%
REGENERON PHARMACEUTICALS-21.34%-20.27%0.59%
SEATTLE GENETICS INC6.19%41.14%1.70%
UNITED THERAPEUTICS CORP-35.38%-23.99%1.81%
VERTEX PHARMACEUTICALS INC5.39%12.49%1.46%
ALNYLAM PHARMACEUTICALS INC-14.49%14.35%1.50%
GRIFOLS SA-ADR8.89%21.81%0.73%
ALLERGAN PLC-13.94%22.52%1.34%
BLUEBIRD BIO INC-25.50%19.26%-2.67%
IONIS PHARMACEUTICALS INC35.49%33.46%1.65%
NEUROCRINE BIOSCIENCES INC-14.05%37.73%1.36%
QIAGEN NV-9.00%1.02%1.84%
IQVIA HOLDINGS INC28.30%35.31%1.53%
NEKTAR THERAPEUTICS-72.55%-48.25%-0.58%
EXACT SCIENCES CORP138.22%88.95%-0.19%
SAREPTA THERAPEUTICS INC-21.40%-6.99%-0.56%
BEIGENE LTD-ADR-10.59%4.12%0.61%
Up